Format

Send to

Choose Destination
Expert Rev Hematol. 2016 Sep;9(9):821-3. doi: 10.1080/17474086.2016.1211006. Epub 2016 Aug 2.

Measuring quality of life in acute myeloid leukemia: limitations and future directions.

Author information

1
a Hematology/Oncology Fellowship Program , University of Washington , Seattle , WA , USA.
2
b Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.
3
c Department of Medicine, Division of Medical Oncology , University of Washington , Seattle , WA , USA.
4
d Department of Medicine, Division of Hematology , University of Washington , Seattle , WA , USA.
5
e Department of Epidemiology , University of Washington , Seattle , WA , USA.

KEYWORDS:

Acute myeloid leukemia; clinical trial; endpoint; patient-reported outcomes; quality of life

PMID:
27389467
PMCID:
PMC5147739
DOI:
10.1080/17474086.2016.1211006
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center